BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7698151)

  • 1. Immunolocalization of transitional cell carcinoma of the bladder with intravesically administered technetium-99m labelled HMFG1 monoclonal antibody.
    Malamitsi J; Zorzos J; Varvarigou AD; Archimandritis S; Dassiou C; Skarlos DV; Dimitriou P; Likourinas M; Zizi A; Proukakis C
    Eur J Nucl Med; 1995 Jan; 22(1):25-31. PubMed ID: 7698151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotargeting of urothelial cell carcinoma with intravesically administered Tc-99m labeled HMFG1 monoclonal antibody.
    Malamitsi J; Zorzos J; Varvarigou AD; Archimandritis S; Dassiou C; Sivolapenko G; Skarlos DV; Serefoglou A; Lykourinas M; Proukakis C
    Cell Biophys; 1994; 24-25():75-81. PubMed ID: 7736542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical administration of radiolabelled tumour-associated monoclonal antibody in bladder cancer.
    Syrigos KN; Khawaja M; Krausz T; Williams G; Epenetos AA
    Acta Oncol; 1999; 38(3):379-82. PubMed ID: 10380831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoscintigraphy with iodine-131-labelled monoclonal antibody AUA1 in patients with transitional cell carcinoma of the bladder.
    Zorzos J; Skarlos DV; Pozatzidou P; Zizi A; Bakiras A; Koritsiadis S; Pectasidis D; Koutsioumba P; Epenetos AA; Likourinas M
    Urol Res; 1994; 22(5):323-7. PubMed ID: 7879319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravesical administration of indium-111-labelled HMFG2 monoclonal antibody in superficial bladder carcinomas.
    Bamias A; Bowles MJ; Krausz T; Williams G; Epenetos AA
    Int J Cancer; 1993 Jul; 54(6):899-903. PubMed ID: 8335396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 99mTechnetium-C595 radioimmunoscintigraphy: a potential staging tool for bladder cancer.
    Simms MS; Perkins AC; Price MR; Scholfield DP; Bishop MC
    BJU Int; 2001 Nov; 88(7):686-91. PubMed ID: 11890238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravesical administration of tumor-associated monoclonal antibody AUA1 in transitional cell carcinoma of the bladder: a study of biodistribution.
    Zorzos J; Skarlos DV; Epenetos AA; Pectasides D; Koutsioumba P; Elemenoglou J; Bakiras A; Likourinas M; Dimopoulos K
    Urol Res; 1993; 21(6):435-8. PubMed ID: 8171767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of bladder cancer with monoclonal antibody NCRC48--a possible approach for intravesical therapy.
    Kunkler RB; Bishop MC; Green DJ; Pimm MV; Price MR; Frier M
    Br J Urol; 1995 Jul; 76(1):81-6. PubMed ID: 7648066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radioimmunoimaging of bladder tumor with the intravesical administration of technetium -99m labelled monoclonal antibody].
    Li N; Yu L; Zhang C
    Zhonghua Wai Ke Za Zhi; 1998 Jan; 36(1):54-6. PubMed ID: 11715544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour localization of radiolabelled monoclonal antibody in mice bearing human urinary bladder (T24) carcinoma xenografts.
    Bubeník J; Kieler J; Perlmann P; Paulie S; Koho H; Christensen B; Dienstbier Z; Koprivová H; Pospísil J; Novák F
    Folia Biol (Praha); 1985; 31(2):176-84. PubMed ID: 3894060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evaluation of copper-67 labelled anti-MUC1 mucin antibody C595 for therapeutic use in bladder cancer.
    Hughes OD; Bishop MC; Perkins AC; Frier M; Price MR; Denton G; Smith A; Rutherford R; Schubiger PA
    Eur J Nucl Med; 1997 Apr; 24(4):439-43. PubMed ID: 9096097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo localisation of human urinary bladder carcinoma xenograft in nude mice using radiolabelled monoclonal antibody.
    Yü DS; Yeh MY; Chen WL; Chang SY; Ma CP; Han SH
    Br J Urol; 1987 Jun; 59(6):540-6. PubMed ID: 3690186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphoma imaging with a new technetium-99m labelled antibody, LL2.
    Murthy S; Sharkey RM; Goldenberg DM; Lee RE; Pinsky CM; Hansen HJ; Burger K; Swayne LC
    Eur J Nucl Med; 1992; 19(6):394-401. PubMed ID: 1618230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I/II clinical trial of the humanized anti-EGF-r monoclonal antibody h-R3 labelled with 99mTc in patients with tumour of epithelial origin.
    Torres LA; Perera A; Batista JF; Hernández A; Crombet T; Ramos M; Neninger E; Pérez M; Sánchez EL; Romero S; Aguilar V; Coca MA; Iznaga-Escobar N
    Nucl Med Commun; 2005 Dec; 26(12):1049-57. PubMed ID: 16264350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting superficial bladder cancer by the intravesical administration of copper-67-labeled anti-MUC1 mucin monoclonal antibody C595.
    Hughes OD; Bishop MC; Perkins AC; Wastie ML; Denton G; Price MR; Frier M; Denley H; Rutherford R; Schubiger PA
    J Clin Oncol; 2000 Jan; 18(2):363-70. PubMed ID: 10637251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted diagnosis and treatment of superficial bladder cancer with monoclonal antibody BDI-1.
    Yu L; Gu F; Zhang C; Xie S; Guo Y
    Chin Med J (Engl); 1998 May; 111(5):404-7. PubMed ID: 10374347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical and immunocytochemical study of bladder carcinomas using the epithelium-specific, tumour-associated monoclonal antibodies HMFG1 and AUA1.
    Anagnostaki E; Skarlos D; Tamvakis N; Psaropoulou P; Blana E; Bamias A; Legaki S; Aravantinos G; Deliveliotis C; Dimopoulos K
    Br J Cancer Suppl; 1990 Jul; 10():52-6. PubMed ID: 2200496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted diagnosis of bladder and ureteral carcinoma using radiolabelled BDI-1.
    Zhang CL; Yu LZ; Gu FL; Buka SD; Zu SL; Xie SS; Pan ZY
    Urol Res; 1998; 26(5):343-8. PubMed ID: 9840344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravesical administration of radiolabeled antitumor monoclonal antibody in bladder carcinoma.
    Bamias A; Keane P; Krausz T; Williams G; Epenetos AA
    Cancer Res; 1991 Jan; 51(2):724-8. PubMed ID: 1985790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostatic radioimmunoscintigraphy: preliminary results using technetium-labelled monoclonal antibody, CYT-351.
    Feneley MR; Chengazi VU; Kirby RS; Nimmon CC; Granowska M; Mather SJ; Ellison D; Granowski AR; Britton KE
    Br J Urol; 1996 Mar; 77(3):373-81. PubMed ID: 8814841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.